Weill Medical College of Cornell University: Lymphoma trials

The registry lists 24 Lymphoma studies with Weill Medical College of Cornell University as lead sponsor. 0 are open to participants now and 14 have results posted.

Early Phase 1 1Phase 1 10Phase 2 13No phase 5(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• CC486-CHOP in Patients With Previously Untreated Peripheral T-cell LymphomaCompletedNCT03542266Phase 2Results posted
• Bendamustine Bridge to Autologous or Allogeneic Transplant for Relapsed/Refractory LymphomaCompletedNCT02059239Phase 1/2Results posted
• Targeting the IPA and Matching for the Non-Inherited Maternal Antigen for Haplo-Cord TransplantationCompletedNCT01810588Phase 2Results posted
• Randomized HaploCord Blood Transplantation vs. Double Umbilical Cord Blood Transplantation for Hematologic MalignanciesTerminatedNCT01745913Phase 2Results posted
• Lenalidomide Plus Rituxan for Untreated Mantle Cell LymphomaCompletedNCT01472562Phase 2Results posted
• Combination Veltuzumab and Fractionated 90Y- Epratuzumab Radioimmunotherapy in Follicular LymphomaTerminatedNCT01147393Phase 1/2Results posted
• Study of 5-azacitidine in Combination With Vorinostat in Patients With Relapsed or Refractory Diffuse Large b Cell Lymphoma (DLBCL)CompletedNCT01120834Phase 1/2Results posted
• Phase I/II Trial of R-CHOP + Azacytidine in Diffuse Large B Cell LymphomaCompletedNCT01004991Phase 1/2Results posted
• A Study to Evaluate the Safety and Efficacy of Dasatinib (Sprycel) in Subjects With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL)TerminatedNCT00918463Phase 2Results posted
• Pilot Study of Abbreviated Chemotherapy Based on Positron Emission Tomography (PET) Scan in Hodgkin's LymphomaTerminatedNCT00901303Not applicableResults posted
• Phase II Study of "VIPER" Chemotherapy in Rel/Ref DLBCLCompletedNCT00504751Phase 2Results posted
• Bevacizumab + CHOP-Rituximab in Untreated Mantle Cell LymphomaCompletedNCT00401817Phase 2Results posted
• Phase I/II Trial of VELCADE + CHOP-Rituximab in Untreated DLCBL or Mantle Cell NHLCompletedNCT00151320Phase 1/2Results posted
• Phase II Study of RT-PEPC in Relapsed Mantle Cell LymphomaCompletedNCT00151281Phase 2Results posted
• Ketogenic Diet in Patients With Untreated Low Tumor Burden Mantle Cell LymphomaWithdrawnNCT04231734Not applicable
• A Pilot Investigator-Initiated Study of Ribavirin in Indolent Follicular Lymphoma and Mantle Cell LymphomaTerminatedNCT03585725Early Phase 1
• Study of Venetoclax Plus DA-EPOCH-R for the Treatment of Aggressive B-Cell LymphomasCompletedNCT03036904Phase 1
• KPT-330 Plus RICE for Relapsed/Refractory Aggressive B-Cell LymphomaCompletedNCT02471911Phase 1
• Longitudinal Survey Analysis in Lymphoma SurvivorsCompletedNCT01469754
• Trial of PD 0332991 Plus Bortezomib in Patients With Relapsed Mantle Cell LymphomaTerminatedNCT01111188Phase 1
• Phase 1 Study of Radiosensitization Using Bortezomib in Relapsed Non-Hodgkin's Lymphoma Patients Receiving RadioimmunotherapyCompletedNCT00777114Phase 1
• Early Response Assessment in Diffuse Large B-Cell Lymphoma (DLCL) Patients by 18-fluoro-2-deoxyglycose Positron Emission Tomography (FDG-PET)CompletedNCT00754117
• Health and Psychosocial Outcomes in Long-Term Lymphoma SurvivorsCompletedNCT00713882
• Study of CHOP + Campath for T-Cell, Null Cell, or Natural Killer (NK)-Cell LymphomaCompletedNCT00161590Phase 1